Cargando…

Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma

Detalles Bibliográficos
Autores principales:	BATINAC, Tanja, HLAČA, Nika, SIMETIĆ, Luka, VALKOVIĆ, Frane, PETERNEL, Sandra, PRPIĆ-MASSARI, Larisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558335/ https://www.ncbi.nlm.nih.gov/pubmed/35146529 http://dx.doi.org/10.2340/actadv.v102.1433

Ejemplares similares

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
por: Shaikh, Saba S., et al.
Publicado: (2022)

Current Concepts of Vitiligo Immunopathogenesis
por: Hlača, Nika, et al.
Publicado: (2022)

Comprehensive Insight into Lichen Planus Immunopathogenesis
por: Vičić, Marijana, et al.
Publicado: (2023)

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023)

Cobimetinib- and vemurafenib-induced granulomatous dermatitis and erythema induratum: A case report
por: Iafolla, Marco AJ, et al.
Publicado: (2019)

Stevens-Johnson Syndrome
por: Laun, Jake, et al.
Publicado: (2016)

Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients
por: Daud, Adil, et al.
Publicado: (2017)

Estimated Cost-effectiveness of Atezolizumab Plus Cobimetinib and Vemurafenib for Treatment of BRAF V600 Variation Metastatic Melanoma
por: Cai, Chao, et al.
Publicado: (2021)

"Síndrome de Stevens-Johnson"
por: Mortera Carbonell, María de los Angeles
Publicado: (1992)

Stevens Johnson Syndrome – “Steven Who? And Why I Should Care About His Johnson?”
por: Cardon, Zachary E., et al.
Publicado: (2019)

Ocular Changes in Metastatic Melanoma Patients Treated with MEK Inhibitor Cobimetinib and BRAF Inhibitor Vemurafenib
por: Gavric, Ana Ursula, et al.
Publicado: (2018)

Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice
por: Álamo, Mª del Carmen, et al.
Publicado: (2021)

Vemurafenib- and Cobimetinib-Associated Drug Reaction With Eosinophilia and Systemic Symptoms in a Patient With Metastatic Melanoma
por: Al-Saedy, Miriam, et al.
Publicado: (2023)

Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab
por: Lopez, Michael, et al.
Publicado: (2023)

The evolution of combined molecular targeted therapies to advance the therapeutic efficacy in melanoma: a highlight of vemurafenib and cobimetinib
por: Medina, Theresa M, et al.
Publicado: (2016)

Cataract surgery in Steven Johnson syndrome
por: Srinivasan, Renuka, et al.
Publicado: (2007)

Stevens-Johnson Syndrome Induced by Vandetanib
por: Yoon, Jimi, et al.
Publicado: (2011)

Stevens Johnson Syndrome associated with Lamotrigine
por: Parveen, Shama, et al.
Publicado: (2013)

Management of severe Stevens–Johnson syndrome
por: Calota, Dan, et al.
Publicado: (2013)

Stevens-Johnson syndrome caused by cefepime?
por: Luciano, Mavilia, et al.
Publicado: (2015)

An unusual cause of Steven-Johnson Syndrome
por: De Guido, Claudia, et al.
Publicado: (2020)

Multidisciplinary care in Stevens-Johnson syndrome
por: Shanbhag, Swapna S., et al.
Publicado: (2020)

The Ocular Microbiome in Stevens-Johnson Syndrome
por: Kittipibul, Thanachaporn, et al.
Publicado: (2021)

A Case of Guillain-Barré Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrosis Overlap After Pembrolizumab Treatment
por: Oguri, Tomoyo, et al.
Publicado: (2021)

Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature
por: Wu, Jing-Yi, et al.
Publicado: (2022)

Stevens - Johnson Syndrome Induced by Sodium Valproate
por: Kumar, P.N. Suresh, et al.
Publicado: (2004)

Steven-Johnson syndrome due to ayurvedic drugs
por: Shivamurthy, Raghu Prasada M., et al.
Publicado: (2012)

Toxic epidermal necrolysis and Stevens-Johnson syndrome
por: Harr, Thomas, et al.
Publicado: (2010)

An analysis of drug induced Stevens-Johnson syndrome
por: Patel, P. P., et al.
Publicado: (2012)

Stevens Johnson syndrome and neurotoxic effects of metronidazole
por: Magazine, Rahul, et al.
Publicado: (2014)

Curcumin in Stevens-Johnsons Syndrome: Culprit or Bystander?
por: Irani, Carla, et al.
Publicado: (2009)

Stevens-Johnson syndrome caused by Cefepime: Erratum
Publicado: (2015)

Lingual botryomycoma in the aftermath of Stevens-Johnson syndrome
por: Moundib, Houyam, et al.
Publicado: (2015)

Stevens–Johnson syndrome following cataract surgery
por: Wu, Shin-Hua, et al.
Publicado: (2015)

Stevens-Johnson Syndrome: Report of a Case
por: Alexander, J. O'D.
Publicado: (1949)

Stevens-Johnson syndrome and abuse of anabolic steroids
por: Cocca, Serena, et al.
Publicado: (2017)

Spectrum of gastrointestinal involvement in Stevens - Johnson syndrome
por: Jha, Ashish Kumar, et al.
Publicado: (2019)

Stevens-Johnson Syndrome Due to Influenza Vaccination
por: Tong, Jonathan, et al.
Publicado: (2020)

Stevens-Johnson Syndrome: A Perplexing Diagnosis
por: Dutt, Jonathan, et al.
Publicado: (2020)

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
por: Klimas, Natasha, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g2iq8dj1dbjq6l0vrrg7ps8sak